Biofrontera (BFRI) EBT (QoQ) (2020 - 2025)
Biofrontera (BFRI) EBT (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 184.90% |
| Sep 30, 2025 | -25.27% |
| Jun 30, 2025 | -26.14% |
| Mar 31, 2025 | -200.50% |
| Dec 31, 2024 | 75.31% |
| Sep 30, 2024 | -2,290.72% |
| Jun 30, 2024 | 97.73% |
| Mar 31, 2024 | -396.48% |
| Dec 31, 2023 | 155.51% |
| Sep 30, 2023 | 35.45% |
| Jun 30, 2023 | -31.45% |
| Mar 31, 2023 | -168.43% |
| Dec 31, 2022 | -8.54% |
| Sep 30, 2022 | -201.76% |
| Jun 30, 2022 | -115.20% |
| Mar 31, 2022 | 138.56% |
| Dec 31, 2021 | 9.41% |
| Sep 30, 2021 | -342.52% |
| Jun 30, 2021 | -2.38% |
| Mar 31, 2021 | -1,779.26% |